Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis

BACKGROUND: We performed a retrospective analysis of data from a phase II study evaluating sorafenib in patients with advanced hepatocellular carcinoma (HCC) to assess differences in safety and efficacy based on Child-Pugh (CP) status (A/B). METHODS: Patients received sorafenib 400 mg PO bid. We ana...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Abou-Alfa, Ghassan K., Amadori, Dino, Santoro, Armando, Figer, Arie, De Greve, Jacques, Lathia, Chetan, Voliotis, Dimitris, Anderson, Sibyl, Moscovici, Marius, Ricci, Sergio
Formato: Artigo
Idioma:Inglês
Publicado: International Society of Gastrointestinal Oncology 2011
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3109886/
https://ncbi.nlm.nih.gov/pubmed/21673874
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares